The current AIM market cap is 21.49M. The company's latest EPS is USD -0.5930 and P/E is -3.04.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 21k | 56k | 49k | 42k | 46k |
Operating Income | -6.61M | -5.56M | -4.3M | -5.46M | -8.16M |
Net Income | -6.39M | -4.39M | -3.66M | -4.91M | -7.82M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 140k | 163k | 135k | 141k | 202k |
Operating Income | -12.44M | -15.02M | -17.06M | -19.92M | -31.92M |
Net Income | -9.53M | -14.4M | -19.13M | -19.45M | -28.96M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 46.29M | 40.49M | 37.46M | 33.62M | 27.86M |
Total Liabilities | 3.59M | 2.02M | 2.47M | 3.48M | 5.26M |
Total Equity | 42.7M | 38.47M | 34.99M | 30.14M | 22.6M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 20.22M | 64.58M | 57.7M | 40.49M | 19.38M |
Total Liabilities | 7.31M | 3.29M | 820k | 2.02M | 9.15M |
Total Equity | 12.91M | 61.29M | 56.88M | 38.47M | 10.23M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.04M | -16.11M | -3.68M | -5.84M | -11.51M |
Investing | 7.63M | 10.99M | -78k | -282k | -618k |
Financing | 80k | 80k | 100k | 105k | 338k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -9.07M | -10.37M | -13.97M | -16.11M | -21.27M |
Investing | -6.15M | -9.16M | -631k | 10.99M | -832k |
Financing | 16.39M | 56.56M | 8.19M | 80k | 485k |
Market Cap | 21.49M |
Price to Earnings Ratio | -3.04 |
Price to Sales Ratio | 439.02 |
Price to Cash Ratio | 16.16 |
Price to Book Ratio | 8.59 |
Dividend Yield | - |
Shares Outstanding | 48.84M |
Average Volume (1 week) | 145.51k |
Average Volume (1 Month) | 319.74k |
52 Week Change | -12.00% |
52 Week High | 0.7487 |
52 Week Low | 0.3201 |
Spread (Intraday) | 0.02 (4.55%) |
Company Name | AIM ImmunoTech Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.aimimmuno.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.